Riverside County Substance Use Program DBA Temecula Substance Use Program
-
Services:
- Substance use treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- Regular outpatient treatment
- Intensive outpatient treatment
- Outpatient
- Screening for tobacco use
- Screening for substance use
- Comprehensive substance use assessment
- Interim services for clients
- Screening for mental disorders
- Outreach to persons in the community
- Sliding fee scale (fee is based on income and other factors)
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- Sign language services for the deaf and hard of hearing
- Spanish
- Buprenorphine maintenance
- Accepts clients using MAT but prescribed elsewhere
- Prescribes buprenorphine
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Criminal justice (other than DUI/DWI)/Forensic clients
- Pregnant/postpartum women
- Adult men
- Adult women
- Clients with co-occurring mental and substance use disorders
- Adolescents
- Clients who have experienced trauma
- Young adults
- Local, county, or community government
- Treatment for gambling disorder
- Breathalyzer or blood alcohol testing
- Drug or alcohol urine screening
- Drug and alcohol oral fluid testing
- Trauma-related counseling
- Substance use disorder counseling
- Relapse prevention
- Matrix Model
- Contingency management/motivational incentives
- Motivational interviewing
- Anger management
- Cognitive behavioral therapy
- Brief intervention
- Telemedicine/telehealth therapy
- Male
- Female
- Adults
- Children/Adolescents
- Assistance with obtaining social services
- Housing services
- Mentoring/peer support
- State Substance use treatment agency
- Private health insurance
- Federal, or any government funding for substance use treatment programs
- Cash or self-payment
- Federal military insurance (e.g., TRICARE)
- IHS/Tribal/Urban (ITU) funds
- Medicaid
- State-financed health insurance plan other than Medicaid
- Medicare
- SAMHSA funding/block grants
- Naltrexone (extended-release, injectable)
- Buprenorphine (extended-release, injectable)
- Buprenorphine with naloxone
- Disulfiram
- Acamprosate (Campral�)
- In-network prescribing entity
- Other contracted prescribing entity
- No formal relationship with prescribing entity
- Mental health services
- Social skills development
- Transportation assistance
- Case management service
- Child care for clients’ children
- No formal relationship with prescribing entity
- In-network prescribing entity
- Other contracted prescribing entity
- Smoking/vaping/tobacco cessation counseling
- Family counseling
- Individual counseling
- Group counseling
- Substance use disorder education
- Health education services other than HIV/AIDS or hepatitis
- Vaping permitted in designated area
- Smoking permitted in designated area
- Outcome follow-up after discharge
- Discharge Planning
- Aftercare/continuing care
- Naloxone and overdose education
Type of Care
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Assessment/Pre-treatment
Payment Assistance Available
Type of Alcohol Use Disorder Treatment
Language Services
Type of Opioid Treatment
Opioid Medications used in Treatment
Special Programs/Groups Offered
Facility Operation (e.g., Private, Public)
Other Services
Testing
Treatment Approaches
Gender Accepted
Age Groups Accepted
Recovery Support Services
License/Certification/Accreditation
Payment/Insurance/Funding Accepted
Pharmacotherapies
External Source of Medications Used for Alcohol Use Disorder Treatment
Ancillary Services
External Opioid Medications Source
Education and Counseling Services
Facility Vaping Policy
Facility Smoking Policy
Transitional Services